• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Dova Pharmaceuticals

















what do you mean big pharma leaders? Isn’t that usually what happens at start ups? Leaders don’t want to be in big pharma so they go to a smaller company?

No, that is not what usually happens at start ups. If you’re got a start up with nobody that has any experience at a start up, then you are in for a very rocky ride. Do your homework.